A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure

Clinical trial NCT02135861 · COMPLETED

Trial details

NCT number: NCT02135861
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Heart Failure, Congestive

Start date: 2014-07-30
Primary completion: 2017-02-22
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.